*By the Jase Medical Clinical team*

Most Americans think of war as something that happens somewhere else, visible mainly through a screen. The Iran conflict has found its way into something far more intimate: the medicine bottles in your bathroom cabinet.Since Iran closed the Strait of Hormuz in March 2026, a quiet crisis has been unfolding in America’s pharmaceutical supply chain.

Most families haven’t felt it yet.
But they will.

The Hidden Anatomy of Your Prescription

The pills we Americans swallow are rarely wholly American-made. The US has no domestic source for more than 80% of essential medicine APIs¹, and the vast majority of what we do import comes from India and China. You’re saying, ok, that’s fine, because everything in America is made in China. Where it matters is that those ingredients travel to manufacturing plants via container ships that, until recently, transited the Persian Gulf which is where the Strait of Hormuz is located.

The Strait of Hormuz carries approximately 20% of the world’s oil and liquefied natural gas². Petrochemicals are also the basis for the plastic packaging on prescription bottles, the chemical precursors that go into the medications themselves, the manufacturing inputs upstream of both, and the fuel that moves all of it around the world. When the strait closes, the ripple effect doesn’t stop at the gas pump. Those ripples really rock the pharmacy world.

Sir Jim Mackey, NHS England’s chief executive, publicly said he is “really worried” about pharmaceutical supply chain challenges³, and the US faces the same exposure.

CNBC reported in March that the Hormuz closure puts America’s generic drug prescriptions at measurable risk⁴. And just skipping this shipping lane doesn’t solve our supply chain problems either: more than half of biopharmaceuticals ship by air cargo⁵. With fuel prices surging and Middle East flight routes canceled, even drugs that don’t originate near the Gulf are getting more expensive to move.

What Does This Mean For You?

The medications most at risk are the ones you’d least want to run out of: generic antibiotics, blood pressure medications, diabetes drugs, thyroid hormones, psychiatric medications, and pain management drugs. These are the workhorses of American healthcare and staples in your own medicine cabinet. Cheap, prescribed daily, ubiquitous on every formulary, and almost entirely dependent on an intact global supply chain.

In a prolonged disruption, “just-in-time” pharmacy inventory models fail. Retail pharmacies typically hold only 2-4 weeks of stock⁶….and that’s without a run on supplies if people start feeling desperate and asking for larger amounts. Hospitals run leaner. The federal Strategic National Stockpile was not designed for a sustained pharmaceutical supply disruption of this scale⁷ and can’t be relied upon for an entire country during a war that isn’t likely to be over very soon.

The families who feel this first are those living prescription-to-prescription, with no backup supply and no plan.

The Physician’s Honest Assessment

I’ve spent my career in emergency and family medicine. I’ve watched patients ration insulin to stretch a vial another two weeks. I’ve watched them stop antibiotics early to save a few pills for next time. I’ve watched them put off a refill on a maintenance medication they’d taken every day for ten years because the pharmacy was backordered. I’ve watched them give up entirely when the backorder stretched too long. Those were peacetime failures, inside a fully functioning supply chain.

What we’re entering now is different. Supply chain disruptions compound. Prices rise before shortages appear, which gives you a window to act if you’re paying attention.

This is a call to prepare appropriately.

What You Can Do Right Now

The most important step a family can take right now is to stop depending on the assumption that whatever you need will be available at your pharmacy next Tuesday.

That means:

• Talk to your physician about a 90-day supply of any critical maintenance medications. Many insurance plans allow it. Ask.
• Prioritize antibiotics in your emergency kit. Bacterial infections don’t pause for supply chain crises.
• Understand which medications in your household are generics with overseas-sourced ingredients. (Hint: Most of them are).
• Build a relationship with a direct-care or telehealth provider who can guide you clinically when hospitals are overwhelmed and pharmacy shelves are thin.

At Jase Medical, we built our emergency antibiotic kits around exactly this reality. A physician, a prescription, an available pharmacy, and the time to get all three aligned will not always show up together when you need them most. A JaseCase puts clinical-grade antibiotics in your hands, prescribed by a real physician and packaged with clear dosing guidance, ready before the crisis arrives. The clinical work is done before you need it.

The Bottom Line

The Iran conflict is a supply chain event and a public health event as much as a geopolitical one. Right now, while most Americans are watching the news instead of checking their medicine cabinets, there is still time to act

The window for preparation closes the day the shortage notice posts on the pharmacy website. That window is still open. Use it.

Build your medical safety net before supply chains tighten further. Visit jase.com to learn about our physician-prescribed emergency antibiotic kits and preparedness resources.

This article is for educational purposes and does not constitute medical advice. Consult a physician for diagnosis and treatment of any illness.

Sources:

1. U.S. Pharmacopeia and FDA reporting: greater than 80% of active pharmaceutical ingredients for essential medicines and key therapeutic areas have no US manufacturing source. The majority of imported APIs come from India and China. https://qualitymatters.usp.org/over-half-active-pharmaceutical-ingredients-api-prescription-medicines-us-come-india-and-european
2. U.S. Energy Information Administration, “Amid regional conflict, the Strait of Hormuz remains critical oil chokepoint” and “About one-fifth of global LNG trade flows through the Strait of Hormuz.” Approximately 20% of global petroleum liquids and 20% of global LNG trade transit the strait. https://www.eia.gov/todayinenergy/detail.php?id=65504 and https://www.eia.gov/todayinenergy/detail.php?id=65584
3. Sir Jim Mackey, NHS England Chief Executive, public comments in late March 2026, reported by LBC. https://www.lbc.co.uk/article/nhs-england-iran-war-supplies-warning-5HjdX7J_2/
4. CNBC, “Strait of Hormuz standoff puts supply of America’s generic drug prescriptions at risk,” March 16, 2026. https://www.cnbc.com/2026/03/16/strait-of-hormuz-closure-generic-drug-prescriptions.html
5. IATA, Healthcare Cargo Handling & Transport: more than 50% of biopharmaceuticals move by air. https://www.iata.org/en/programs/cargo/pharma/
6. NCPA Digest data: average retail pharmacy turns inventory 12.2 times per year (~30-day stock cycle); 2-4 weeks is a defensible range. CNBC (source #4) notes pharmaceutical distributors carry 30-60 days at a layer up. https://ncpa.org/
7. HHS/ASPR Strategic National Stockpile, “Sustaining the Stockpile.” Built for acute large-scale public health emergencies (CBRN threats, pandemics, natural disasters), not sustained outpatient prescription disruption. The August 2025 SAPIR Executive Order separately directs ASPR to build a Strategic Active Pharmaceutical Ingredients Reserve, an explicit acknowledgment that the existing SNS does not cover this. https://aspr.hhs.gov/SNS/Pages/Sustaining-the-Stockpile.aspx

*By the Jase Medical Clinical team*

For decades, the dream in oncology has been simple and audacious: teach your own immune system to hunt cancer. Not poison it with chemotherapy. Not burn it with radiation. Train your body’s existing defenses to do what they were arguably designed to do — identify and destroy abnormal cells.

That dream is moving from the lab bench to clinical reality faster than most people realize. And what’s emerging isn’t just exciting for cancer patients — it’s a fundamental rethinking of how we relate to our own biology.

The Tumor That Vanished

In March 2026, researchers published results that stopped the oncology world in its tracks. A redesigned immunotherapy approach — injecting a modified CD40 agonist antibody directly into a single tumor — triggered immune responses that eliminated cancer throughout the body.

One injection site. Cancer vanishing elsewhere.

This isn’t the first time researchers have attempted localized immunotherapy. What’s different now is the engineering. Scientists redesigned the antibody structure for greater potency and changed its delivery to maximize the immune cascade effect. Early results describe the response as “striking” — after years of disappointing outcomes with predecessor compounds.

The implications are profound. Rather than flooding the entire body with systemic immunotherapy and its significant toxicities, you prime the immune system at one location — and let it do the rest. Less collateral damage. Potentially far greater precision.

Your Diet May Be a Cancer-Fighting Tool

Just last week, another study added a quieter but equally important piece to the puzzle. Researchers found that zeaxanthin — a carotenoid found naturally in eggs, leafy greens, and orange peppers — slowed tumor growth in mouse models. More importantly, the effect became dramatically more pronounced when combined with immune checkpoint inhibitors, the same class of drugs that has already transformed treatment for melanoma and lung cancer.

In other words: a common dietary nutrient appears to amplify one of the most powerful classes of cancer therapy we currently have.

This is not a cure. Mouse studies don’t always translate directly to humans. But this is exactly the kind of signal that deserves serious attention — particularly because zeaxanthin is safe, inexpensive, and widely available. For health-conscious families, it’s a compelling reminder that what’s on your plate is not neutral. Diet is medicine.

Reprogramming Immune Cells — Inside the Body

Perhaps the most technically remarkable development comes from scientists who have found a way to reprogram cancer-fighting immune cells directly inside the body — no extraction, no lab, no weeks of manufacturing.

Current CAR-T cell therapy — one of the most promising cancer treatments in existence — requires exactly that laborious process: extract T-cells from the patient, genetically modify them over weeks in specialized facilities, then reinfuse them. It’s effective for certain blood cancers. It’s also extraordinarily expensive and logistically out of reach for most of the world.

The new in-body reprogramming approach uses targeted delivery mechanisms to trigger immune cell modification *in vivo* — inside you, in real time. Early results show rapid tumor clearance. If this technology scales, it could fundamentally democratize access to immunotherapy beyond major cancer centers.

What This Means for You — Right Now

You don’t need to wait for phase three trials to take these signals seriously. Here’s what the evidence already supports.

Eat your carotenoids. Eggs, kale, corn, orange peppers, and spinach are all rich in zeaxanthin and lutein. If immune checkpoint inhibitors are part of your treatment picture, talk to your oncologist about the emerging dietary synergy research.

Know your immune baseline. Chronic inflammation, metabolic dysfunction, and nutrient deficiencies all blunt immune response. The same immune system these researchers are working to harness is the one protecting you every day.

Don’t dismiss early-stage research. The CD40 agonist approach looked impossible a decade ago. In-body CAR-T reprogramming sounded like science fiction five years ago. The pace of translation from bench to bedside is accelerating.

The Preparedness Angle

At Jase Medical, we often talk about preparedness in the context of acute emergencies — the antibiotic kit for when a pharmacy isn’t available, the medical supplies for when healthcare infrastructure fails. But genuine preparedness extends to your long-term health resilience.

The families we serve ask hard questions: What if I or someone I love faces a serious diagnosis in a disrupted healthcare environment? What does it mean to be truly healthy — not just symptom-free? These immunotherapy breakthroughs belong in that conversation. Understanding your immune system is foundational — and it’s exactly the kind of physician-graded intelligence we’re committed to delivering.

Take the Next Step

If this kind of health intelligence matters to your family, subscribe to the Jase Medical newsletter at Jase.com for regular updates at the intersection of cutting-edge medicine and practical preparedness.

And if you haven’t yet built your family’s medical foundation, explore the JaseCase — because the best time to prepare is always before you need it.

This article is for educational purposes and does not constitute medical advice. Consult a physician for diagnosis and treatment of any illness.

Learn more about Jase Medical’s emergency preparedness kits and other medication solutions at jase.com

*Sources: ScienceDaily (March 15, 2026 — CD40 agonist localized immunotherapy); ScienceDaily (April 10, 2026 — zeaxanthin + immune checkpoint inhibitors); SciTechDaily (in-body immune cell reprogramming, 2026)*

*By the Jase Medical Clinical team*

I want to tell you something that caught my attention as a physician before it caught my attention as a CEO.

A few weeks ago I was reading through case reports from colleagues in the Northeast. Family docs, internists, infectious disease specialists. The pattern was impossible to ignore. They’re seeing tick-borne illness earlier in the year, in places they’ve never seen it, in patients who had no idea they were at risk. One physician in Vermont told me he treated his first Lyme case of the year in February.

February.

That’s not a talking point. That’s a clinical data point. And it tells you everything you need to know about where we are headed this spring and summer.

What’s Actually Happening

Tick populations have been expanding geographically for over a decade. Milder winters. Shifting wildlife corridors. More human activity in tick-dense areas. None of that is new. What is new — what makes 2026 different — is that the species carrying the most dangerous pathogens have now established permanent populations in regions that were considered safe as recently as five years ago.

The black-legged tick, Ixodes scapularis — the one responsible for Lyme disease — is not a visitor anymore in places like the upper Midwest and northern New England. It lives there now. And it’s active earlier in the spring and later into the fall, which means the old “May through August” tick season guidance is increasingly meaningless.

Physicians in northern states are treating tick-borne illness before the snow is off the ground.

Four Diseases, One Vulnerability

Most people hear “tick bite” and think Lyme disease. That’s understandable. Lyme is the most common tick-borne illness in the US, with over 476,000 cases diagnosed annually. The classic bullseye rash, the flu-like onset, the joint pain and neurological complications that follow when treatment is delayed — it’s serious. But it’s not the whole picture.

A single tick bite can transmit any of four major bacterial infections. Each one carries real consequences.

Lyme Disease (Borrelia burgdorferi). First-stage symptoms can look like a bad flu. Left untreated, it becomes something far worse — joint destruction, neurological damage, cardiac involvement. Early treatment changes the trajectory completely.

Anaplasmosis (Anaplasma phagocytophilum). Spread by the same tick as Lyme. Sudden fever, crushing headache, muscle pain. Gets misdiagnosed as flu constantly. In immunocompromised patients, it can progress to respiratory failure and organ damage.

Ehrlichiosis (Ehrlichia chaffeensis). Spread primarily by the lone star tick, whose range has pushed significantly into the Northeast. Fever, fatigue, dangerously low platelet and white blood cell counts. The mortality rate for untreated ehrlichiosis is meaningfully higher than Lyme.

Rocky Mountain Spotted Fever (Rickettsia rickettsii). The name is misleading — RMSF now occurs across much of the continental US. It is the deadliest tick-borne disease in North America. It can kill within days of symptom onset, and the classic spotted rash often shows up late, after the treatment window has already narrowed.

Here’s the Part That Matters

All four of those infections respond to the same antibiotic: doxycycline.

Doxycycline is a broad-spectrum tetracycline with exceptional activity against the intracellular bacteria behind all four diseases. For Lyme, it’s first-line treatment in adults and children over eight. For anaplasmosis, ehrlichiosis, and RMSF, it’s not just first-line — it’s the only reliably effective option.  We supply it in the base JaseCase for a reason. Everyone should have this on hand, just in case.

The CDC and the Infectious Diseases Society of America both recommend initiating doxycycline empirically — based on clinical suspicion alone, before lab results come back — when tick-borne illness is suspected. That recommendation exists because the organisms causing these diseases don’t wait for a confirmation number from the lab. And in the case of RMSF, delaying treatment while waiting on results is directly associated with higher mortality.

As a physician, that’s the piece I need you to understand. The science here is not ambiguous. Early doxycycline changes outcomes.

The Gap That Keeps Me Up at Night

Think about where most people encounter ticks. Hiking trails. Campgrounds. The backyard of a cabin two hours from the nearest urgent care. Even in suburban settings, the timeline from tick bite to symptom onset to physician visit to filled prescription can stretch across days. In serious tick-borne illness — particularly RMSF — those days are the difference between an outpatient course of antibiotics and a hospital bed.

This is the problem I built Jase Medical to solve. Not the theoretical version. The real one. The version where a family on a camping trip pulls a tick off their kid and has no way to act on what they know until Monday morning.

A supply of physician-prescribed doxycycline in your emergency medical kit means you’re not waiting on the system to catch up with the biology. You’re prepared to act when it matters.

What to Do Right Now

Start with prevention. Use EPA-registered repellents — DEET at 20% or higher, picaridin, or permethrin-treated clothing. Do full-body tick checks after any time spent outdoors. Shower within two hours of coming inside. Check your pets; they carry ticks into the home more often than people realize.

Know the warning signs. Unexplained fever with headache and muscle aches after outdoor activity. Any rash, especially one that’s spreading or has a bullseye pattern. If you see those, mention tick exposure to your physician immediately — don’t wait for someone to ask.

Close the gap. Talk to a Jase Medical physician about whether doxycycline and other emergency antibiotics belong in your family’s kit. Don’t wait for a tick-borne illness to find out you weren’t ready.

The 2026 tick surge is not hypothetical. It’s already underway. The physicians sounding the alarm are watching their patient panels and seeing the numbers climb in real time.

The good news is that the single most important medication for treating all four major tick-borne diseases is well understood, widely available, and something you can have on hand before you ever need it.

Be ready before you need to be.

Build Your Emergency Medical Kit with Jase Medical →

This article is for educational purposes and does not constitute medical advice. Consult a physician for diagnosis and treatment of any illness.

Learn more about Jase Medical’s emergency preparedness kits and other medication solutions at jase.com